A
Anton Pozniak
Researcher at Imperial College London
Publications - 270
Citations - 13961
Anton Pozniak is an academic researcher from Imperial College London. The author has contributed to research in topics: Ritonavir & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 53, co-authored 241 publications receiving 13079 citations. Previous affiliations of Anton Pozniak include Oxleas NHS Foundation Trust & Bristol-Myers Squibb.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
Joel E. Gallant,Schlomo Staszewski,Anton Pozniak,Edwin DeJesus,Jamal M. A. H. Suleiman,Michael D. Miller,Dion F. Coakley,Biao Lu,John J. Toole,Andrew K. Cheng +9 more
TL;DR: Through 144 weeks, the combination of tenofovir DF, lamivudine, and efavirenz was highly effective and comparable with stavudine for antiretroviral-naive patients and appeared to be associated with better lipid profiles and less lipodystrophy.
Journal ArticleDOI
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
Joel E. Gallant,Edwin DeJesus,Jose R. Arribas,Anton Pozniak,Brian Gazzard,Rafael Campo,Biao Lu,Damian J McColl,Steven L. Chuck,Jeffrey Enejosa,John J. Toole,Andrew K. Cheng +11 more
TL;DR: The combination of tenofovir DF and emtricitabineplus efavirenz fulfilled the criteria for noninferiority to a fixed dose of zidovudine and lamivudine plus efvirenz and proved superior in terms of virologic suppression, CD4 response, and adverse events resulting in discontinuation of the study drugs.
Journal ArticleDOI
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
Gerd Fätkenheuer,Anton Pozniak,Margaret Johnson,Andreas Plettenberg,Schlomo Staszewski,Andy I. M. Hoepelman,Michael S. Saag,Frank D. Goebel,Jürgen K. Rockstroh,Bruce J. Dezube,Tim M Jenkins,Christine G Medhurst,John F. Sullivan,Caroline E. Ridgway,Samantha Abel,Ian James,Mike Youle,Elna van der Ryst +17 more
TL;DR: Results provide proof of concept that CCR5 antagonism is a viable antiretroviral therapeutic approach for HIV-1-positive individuals prescreened for the absence of CXCR4-using virus.
Journal ArticleDOI
Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load
Heather Donaghy,Anton Pozniak,Brian Gazzard,Nad A. Qazi,Jill Gilmour,Frances Gotch,Steven Patterson +6 more
TL;DR: It is reported that in HIV-1 infection there is a progressive depletion of both myeloid and plasmacytoid dendritic cells and that this correlates with an increasing HIV- 1 plasma virus load.
Journal ArticleDOI
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults
TL;DR: This third version of the EACS guidelines includes, as new topics, the assessment of patients at initial and subsequent clinic visits as well as post‐exposure prophylaxis in the treatment of adults with HIV infection.